Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
24 June 2022
Closing Date:
26 July 2022
Location(s):
BE10 Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest (BE Belgium/BELGIQUE-BELGIË)
Description:
Bosentan

The market concerns supplies of the proprietary medicinal product containing the active substance 'Bosentan' in tablets of 62.5 mg and 125 mg.

The market concerns supplies of the proprietary medicinal product containing the active substance 'Bosentan' in tablets of 62.5 mg and 125 mg.

Download full details as .pdf
The Buyer:
Cliniques universitaires Saint-Luc
CPV Code(s):
33600000 - Pharmaceutical products